Phillip Sharp

Phillip Sharp possessed a profoundly elite, highly decorated background in advanced molecular biology and complex genetic research. Operating at the absolute forefront of global scientific discovery—eventually winning the Nobel Prize in Physiology or Medicine—this unprecedented background in manipulating complex biological mechanisms provided the exact technical authority required to successfully co-found the massive Biogen enterprise.

Phillip Sharp is an incredibly legendary American geneticist, Nobel laureate, and a profoundly influential co-founder of the massive Biogen pharmaceutical empire. Operating as an absolutely elite molecular biologist in 1978, Sharp joined a highly exclusive consortium of international scientists in Geneva to aggressively launch the company. Driven by the incredibly ambitious vision of successfully commercializing the bleeding-edge science of recombinant DNA, Sharp provided the absolute critical scientific credibility and deep technical validation required to secure massive early venture funding. His unprecedented, world-renowned mastery of RNA splicing completely laid the foundational scientific architecture that eventually allowed Biogen to aggressively transition from a highly speculative academic startup into a multi-billion dollar, globally dominant neuroscience and biotechnology monopoly.